CEO Marcus Lemonis Buys $1M of NXH Stock at $2.76
NXH is trading near its 52-week low of $1.744 (4.9% above the low) on elevated volume (6.0× avg).
Summary
CEO Marcus Lemonis bought $1M of NXH stock at $2.76 per share, increasing his direct holdings to 1,076,860 shares.
Key Events · Ownership and Investor Activity · NXH
-
CEO Buys $1M in Open Market
Marcus Lemonis purchased 362,319 shares at $2.76 per share for $1,000,000.44 on October 6, 2026.
-
Post-Transaction Holdings
Lemonis now directly holds 1,076,860 shares, up from 714,541 shares before the purchase.
-
Purchase Price Matches Offering
The $2.76 purchase price equals the price of the $45.5M registered direct offering finalized the prior day, suggesting alignment with the company's financing terms.
-
Near 52-Week Low
The stock trades at $1.83, near its 52-week low of $1.744, making the CEO's $1M buy a notable conviction signal.
Analysis · NXH · Trade & Services
Executive Chairman and CEO Marcus Lemonis bought 362,319 shares for $1,000,000.44 at $2.76 per share on October 6, 2026. This is a real-money open-market purchase, not an option exercise or grant. The buy comes one day after the company finalized a $45.5M registered direct offering at the same $2.76 price, and just after the Fathom Holdings merger was terminated. Lemonis now holds 1,076,860 shares directly. The purchase represents roughly 0.57% of the company's market cap and is a strong insider conviction signal, especially with the stock trading near its 52-week low of $1.744.
How filings like this one have moved
In the 30 days to Oct 22, 2026, 36.9% of the 1029 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.77%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NXH was trading at $1.83 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $174.8M. The 52-week trading range was $1.74 to $12.23. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.